(AVLV) American Century Trust - - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US0250723493 • Large Value
AVLV: Large Cap Stocks, Equities, US Companies
The Avantis U.S. Large Cap Value ETF (AVLV) is designed to provide exposure to large-capitalization U.S. companies that exhibit value characteristics. The fund employs a systematic, rules-based approach to identify and invest in companies with lower valuations relative to their fundamentals. By focusing on large-cap firms, the ETF taps into the stability and proven track records of established businesses.
AVLV maintains a diversified portfolio across various market sectors and industry groups, ensuring that no single area dominates the fund. This diversification aims to mitigate sector-specific risks while capturing broad market exposure. The ETFs managers adhere to a stringent investment policy, allocating at least 80% of its assets to equities of large-cap U.S. companies. This threshold ensures that the fund remains true to its large-cap value mandate.
In determining whether a company qualifies as a U.S. company, the managers consider multiple factors: the companys headquarters location, its principal operations, the geographic source of its revenues, the primary trading market, legal organization, and inclusion in the funds benchmark. This comprehensive approach ensures that the fund accurately reflects the U.S. large-cap value universe.
As an ETF, AVLV offers the benefits of transparency and tradability, with its holdings disclosed daily and listed on the NYSE ARCA exchange. The funds inception in 2021 positions it as a relatively new but growing player in the large-cap value space, with assets under management exceeding $5.7 billion as of recent data. This scale indicates a robust investor base and liquidity.
AVLV is part of the Avantis Investors lineup, which emphasizes evidence-based, systematic investing. The funds strategy avoids emotional or speculative decisions, focusing instead on delivering returns through disciplined, research-driven methodologies. This approach aligns with the preferences of investors seeking a low-cost, efficient way to gain exposure to the large-cap value segment of the U.S. equity market.
Additional Sources for AVLV ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AVLV ETF Overview
Market Cap in USD | 5,692m |
Category | Large Value |
TER | 0.15% |
IPO / Inception | 2021-09-21 |
AVLV ETF Ratings
Growth 5y | 59.5% |
Fundamental | - |
Dividend | 53.3% |
Rel. Strength Industry | -2.79 |
Analysts | - |
Fair Price Momentum | 61.89 USD |
Fair Price DCF | - |
AVLV Dividends
Dividend Yield 12m | 1.61% |
Yield on Cost 5y | 2.19% |
Annual Growth 5y | 61.60% |
Payout Consistency | 78.8% |
AVLV Growth Ratios
Growth Correlation 3m | -1.5% |
Growth Correlation 12m | 86.1% |
Growth Correlation 5y | 83.3% |
CAGR 5y | 9.70% |
CAGR/Max DD 5y | 0.50 |
Sharpe Ratio 12m | -0.02 |
Alpha | -2.95 |
Beta | 0.85 |
Volatility | 18.43% |
Current Volume | 827.9k |
Average Volume 20d | 440.2k |
As of March 09, 2025, the stock is trading at USD 66.60 with a total of 827,919 shares traded.
Over the past week, the price has changed by -3.13%, over one month by -3.60%, over three months by -4.23% and over the past year by +8.96%.
Partly, yes. Based on ValueRay Analyses, American Century Trust - (NYSE ARCA:AVLV) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 59.49 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AVLV as of March 2025 is 61.89. This means that AVLV is currently overvalued and has a potential downside of -7.07%.
American Century Trust - has no consensus analysts rating.
According to ValueRays Forecast Model, AVLV American Century Trust - will be worth about 71.3 in March 2026. The stock is currently trading at 66.60. This means that the stock has a potential upside of +6.98%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 71.3 | 7% |